Ausgabe 6/2011
Inhalt (11 Artikel)
Editorial
Beta-Blocker Dose Up-Titration or Addition of Ivabradine in Stable Angina: More is Not Necessarily Better
Raymond W. Sy, Saul B. Freedman
Editorial
The MAGIC Study and the Gastrointestinal Effects of Low-Dose Aspirin
John McNeil, Andrew Tonkin
Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice
Yumei Ye, Jinqiao Qian, Alexander C. Castillo, Jose Regino Perez-Polo, Yochai Birnbaum
Abdominal Surgical Incision Induces Remote Preconditioning of Trauma (RPCT) via Activation of Bradykinin Receptors (BK2R) and the Cytochrome P450 Epoxygenase Pathway in Canine Hearts
Garrett J. Gross, John E. Baker, Jeannine Moore, John R. Falck, Kasem Nithipatikom
Reduction of Cerebral Infarct Size by Dronedarone
Tobias Engelhorn, Marc A. Schwarz, Gerd Heusch, Arnd Doerfler, Rainer Schulz
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina
E. Amosova, E. Andrejev, I. Zaderey, U. Rudenko, C. Ceconi, R. Ferrari
Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome
Robert S. Rosenson, Heather Fraser, Michael A. Goulder, Colin Hislop
Short Communication
C-Reactive Protein, Statins and the Risk of Vascular Events: A Better Understanding
Behnood Bikdeli
Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study
Hideki Origasa, Shinya Goto, Kazuyuki Shimada, Shinichiro Uchiyama, Yasushi Okada, Kentaro Sugano, Hideyuki Hiraishi, Naomi Uemura, Yasuo Ikeda
Stroke Prevention in Atrial Fibrillation
Jonathan P. Piccini, Thomas W. Wallace, Manesh R. Patel, Richard C. Becker